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Background: Metabolically healthy obese (MHO) phenotype may present with distinct characteristics compared
with those with a metabolically unhealthy obese phenotype. Epidemiologic data on the distribution of these
conditions in the working population are lacking. We aimed to evaluate the prevalence and clinical characteristics
of MHO and other obese/non-obese metabolic phenotypes in a working population.
Methods: Cross-sectional analysis of all subjects who had undergone a medical examination with Ibermutuamur
Prevention Society from May 2004 to December 2007. Participants were classified into 5 categories according to
their body mass index (BMI); within each of these categories, participants were further classified as metabolically
healthy (MH) or metabolically unhealthy (MUH) according to the modified NCEP-ATPIII criteria. A logistic regression
analysis was performed to evaluate some clinically relevant factors associated with a MH status.
Results: In the overall population, the prevalence of the MHO phenotype was 8.6 %. The proportions of MH
individuals in the overweight and obese categories were: 87.1 % (overweight) and 55.5 % (obese I-III [58.8, 40.0, and
38.7 % of the obese I, II, and III categories, respectively]). When the overweight and obese categories were
considered, compared with individuals who were MUH, those who were MH tended to be younger and more likely
to be female or participate in physical exercise; they were also less likely to smoke, or to be a heavy drinker. In the
underweight and normal weight categories, compared with individuals who were MH, those who were MUH were
more likely to be older, male, manual (blue collar) workers, smokers and heavy drinkers. Among participants in the
MUH, normal weight group, the proportion of individuals with a sedentary lifestyle was higher relative to those in
the MH, normal weight group. The factors more strongly associated with the MUH phenotype were BMI and age,
followed by the presence of hypercholesterolemia, male sex, being a smoker, being a heavy drinker, and lack of
physical exercise.
Conclusions: The prevalence of individuals with a MHO phenotype in the working population is high. This
population may constitute an appropriate target group in whom to implement lifestyle modification initiatives to
reduce the likelihood of transition to a MUH phenotype.
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Obesity is a major public health problem. It affects
more than 1.7 billion people and is the sixth most im-
portant risk factor contributing to the overall burden
of disease worldwide [1]. Obesity and overweight have
been associated with an increased risk of developing
type 2 diabetes, dyslipidemia, hypertension, coronary
heart disease, stroke, and cancer, among many other
diseases [1–3], and these conditions are associated
with a reduced life expectancy [4].
Among obese individuals, a phenotype of patients who
do not present metabolic abnormalities, the so-called
metabolically healthy obese (MHO) phenotype, has been
described [5]. The prevalence of the MHO phenotype
varies greatly across studies (2.2–11.9 % of the general
population and 6–40 % of the obese population), depend-
ing on the study design and, particularly, on the criteria
used for its definition [5]. Individuals with this phenotype
could be at a lower risk of developing the aforementioned
health problems compared with metabolically unhealthy
obese (MUHO) individuals. However, recent investiga-
tions have shown that the MHO phenotype is associated
with subclinical cardiovascular markers, an increased risk
of developing diabetes, and even an increased risk of all-
cause mortality and/or cardiovascular events in the long
term [6–9].
MHO individuals may present with distinct characteris-
tics compared with MUHO individuals. Phillips et al.
characterize the former as having less disturbed coordin-
ation of the pathways involved in nutrient handling, insulin
signaling, inflammation, and lipid metabolism, which may
make them more responsive to dietary interventions [5].
Consequently, it may be important to identify individuals
belonging to a MHO or MUHO phenotype to aid selection
of the appropriate therapeutic intervention [10]. In this
context, the working population may be an appropriate
group in whom to apply this management approach. How-
ever, to date, there have not been any studies evaluating
MHO individuals in the working population.
The aim of this study was to evaluate the prevalence
of the MHO and other obese/non-obese metabolic phe-
notypes and their clinical characteristics in a working
population.
Methods
Study design and population
This cross-sectional analysis was part of the Ibermutua-
mur CArdiovascular RIsk Assessment (ICARIA) study.
The methodology of the ICARIA study has been de-
scribed elsewhere [11].
Briefly, the ICARIA project included workers whose
companies have healthcare coverage with Ibermutuamur,
a single nationwide Spanish workers’ compensation insur-
ance company that covers 8 % of the Spanish workingpopulation and includes workers from all activity sectors
and all geographical areas of Spain [12]. To be included in
these analyses, participants had to have undergone a rou-
tine medical examination with Ibermutuamur Prevention
Society between May 2004 and December 2007, and they
had to have information available regarding all variables
included in the definition of “metabolically healthy” (see
later).
Evaluations
The routine medical check-ups included a structured
questionnaire, a physical examination and a laboratory
assessment.
The structured questionnaire included information
on age, sex, specific occupation, tobacco and alcohol
consumption, physical exercise, and medical history.
Regarding occupation, participants were categorized
as either manual (blue-collar) workers or non-manual
(white-collar) workers [13]. Smoking status was cate-
gorized as never smoker, former smoker (stopped
smoking ≥1 year ago), former smoker (stopped smok-
ing <1 year ago), and current smoker. Alcohol con-
sumption was categorized as high if they consumed 14
or more standard drinks per week; the following con-
version guide was used: 1 glass of wine = 1 drink, 1
beer = 1 drink, 1 glass of spirit or mix spirit = 2 drinks.
Individuals’ physical exercise level was categorized
into four groups according to self-reported informa-
tion: no physical exercise, <2 h/week of physical exer-
cise, ≥2 h/week of physical exercise, and regular
physical exercise.
The physical examination included weight, height,
waist circumference, and two blood pressure recordings
from the same arm. Waist circumference was measured
at the midpoint between the lowest rib and the iliac
crest. Blood pressure was measured using a validated
automatic measuring system (OMRON M4-1, Omron
Electronics, Hoofddorp, Netherlands). Laboratory assays
included fasting serum glucose, triglycerides, total chol-
esterol, and high-density lipoprotein (HDL) cholesterol.
Ethical issues
The study was reviewed and approved by the Ethics
Committee of Ibermutuamur (Madrid, Spain). All partic-
ipants provided consent to include their information in
anonymous aggregated analyses for the ICARIA project.
The study was conducted according to the principles of
the Declaration of Helsinki.
Statistical analysis
According to body mass index (BMI), participants were
categorized as underweight (BMI: <18.5 kg/m2), normal
weight (BMI: 18.5–24.99 kg/m2), overweight (BMI:
25.0–29.99 kg/m2) or obese (BMI: ≥30 kg/m2). Obese
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30.0–34.99 kg/m2), obese II (BMI: 35.0–39.99 kg/m2)
or obese III (BMI: ≥40 kg/m2). Metabolic health was
evaluated using the modified criteria for metabolic syn-
drome according to the National Cholesterol Education
Program (NCEP) Adult Treatment Panel III (ATPIII)
guidelines as in previous studies [14]: waist circumfer-
ence >102 cm (>40 in) for men or >88 cm (>35 in) for
women, triglycerides ≥150 mg/dL or receiving treat-
ment for hyperlipidemia, HDL cholesterol <40 mg/dL
for men or <50 mg/dL for women, blood pressure
≥130/85 mmHg or previous diagnosis of hypertension
or receiving treatment for hypertension, fasting glucose
≥100 mg/dL or receiving treatment for diabetes. Com-
bined BMI and metabolic health phenotypes were
defined based on BMI category and whether individuals
met 0 to 2 (metabolically healthy) or 3 or more (meta-
bolically unhealthy) NCEP-ATPIII criteria. As part of
an exploratory analysis, we also used a more stringent
criterion for MHO, that is, obese individuals who did
not meet any criteria of the NCEP-ATPIII guideline.
Continuous outcomes are presented as means (standard
deviations [SD]), and categorical outcomes are presented as
relative frequencies. We also calculated the 95 % confidence
intervals (CIs) for all parameters. Differences among BMI
with metabolically healthy or unhealthy phenotypes were
tested. Chi-squared test was used for categorical variables.
Student t-test and one-way ANOVA were selected to com-
pare groups in quantitative variables.
To evaluate the factors associated with a metabolically
healthy status, a logistic regression analysis was performed
using metabolic unhealthy status as the dependent vari-
able and age categories (≤34, 35–44, 45–54, and ≥55 years),
sex, BMI categories (as described earlier), type of worker,
smoking status, alcohol consumption, presence of hyper-
cholesterolemia and physical exercise as the explanatory
variables.
All analyses were performed using SPSS version 17
(SPSS Inc., Chicago, IL, USA).
Results
During the study period, 451,432 individuals were
assessed and provided data for all of the parameters used
to define metabolic health status.
Prevalence of BMI and metabolic phenotypes
The prevalences of the different BMI categories were as
follows: underweight (1.7 %), normal weight (44.8 %), over-
weight (38.0 %), obese I (12.5 %), obese II (2.4 %) and obese
III (0.6 %). Overall, 70,053 individuals (15.5 %) were obese.
The prevalences of each combination of BMI and
metabolic phenotype in the total study population are
presented in Tables 1, 2 and 3, with overall values of
8.6 % for MHO and 7.0 % for MUHO.The prevalence of a metabolically healthy status was
87.1 % for the overweight individuals and 55.1 % for obese
individuals. Among the various obesity categories, the
prevalence of metabolically healthy individuals was 58.8 %
for obesity I, 40.0 % for obesity II, 38.7 % for obesity III
(Fig. 1). Using the more stringent criteria for defining
metabolically healthy status (none of the 5 NCEP-ATPIII
criteria), there were no individuals with a metabolically
healthy phenotype among the obese II and III categories,
and the proportion of metabolically healthy individuals
among obese I and overweight subjects was 6.4 and
25.7 %, respectively (data not shown).
Among individuals who were underweight or normal
weight, 99.5 and 97.8 %, respectively, were metabolically
healthy using the modified NCEP-ATPIII criteria. Using
the more stringent criteria, proportions were 70.6 and
53.6 %, respectively (data not shown).
Characteristics associated with a metabolically healthy
phenotype among overweight and obese individuals
When the overweight and obese categories were consid-
ered, compared with individuals with metabolically un-
healthy phenotypes, individuals who were metabolically
healthy tended to be younger and more likely to be female
or participate in physical exercise; they were also less likely
to smoke or to be a heavy drinker (Table 1). Overall, the
proportions of blue-collar workers were similar between
healthy and unhealthy phenotypes for the overweight
(69.8 % versus 71.3 %) and obese categories (74.2 % versus
75.2 %).
In MHO individuals, mean values of systolic blood pres-
sure, diastolic blood pressure, HDL cholesterol, and glucose
showed less than 3 % variation among the three categories
of obesity (Table 2). This degree of variation among groups
was statistically significant (p < 0.0001 for all), but was not
deemed clinically relevant. In contrast, mean triglyceride
levels were 115.7 mg/dL, 105.7 mg/dL and 103.7 mg/dL for
these individuals in the obese I, II, and III categories (p <
0.0001), respectively. Similarly, mean total cholesterol levels
were 204.6 mg/dL in obese I, 199.9 mg/dL in obese II, and
196.4 mg/dL in obese III metabolically healthy individuals
(p < 0.0001). Respective mean waist circumferences were
100.6 cm, 110.1 cm, and 116.2 cm (p < 0.0001).
Total cholesterol values were lower in individuals with
the metabolically healthy phenotype compared with those
with the metabolically unhealthy phenotype in both the
overweight (201.4 vs. 217.5 mg/dL) and obese (203.9 vs.
216.1 mg/dL) groups (Table 1).
Characteristics associated with a metabolically unhealthy
phenotype among underweight and normal weight
individuals
In the underweight or normal weight categories, com-
pared with metabolically healthy individuals, those who
Table 1 Characteristics of the study population by metabolic phenotype among overweight and obese individuals
Characteristics Overweight (BMIa 25.00–29.99 kg/m2) Obese All (BMIa ≥30.00 kg/m2) p-value*
n = 171,368 n = 70,052
Healthy Unhealthy Healthy Unhealthy Healthy Unhealthy
n = 149,231 n = 22,137 n = 38,600 n = 31,452
Prevalence, % 33.1 4.9 8.6 7.0
(95 % CI) b (32.9–33.2) (4.8–5.0) (8.5–8.6) (6.9–7.0)
Age (years), mean
[SD]c (95 % CI)b
37.3 [10.5] 44.1 [10.6] 37.7 [10.7] 42.9 [10.7] <0.0001 <0.0001
(37.2–37.4) (44.0–44.3) (37.6–37.8) (42.7–43.0)
Female, % 16.5 11.7 18.4 11.9 <0.0001 0.5889
(95 % CI)b (16.3–16.7) (11.3–12.1) (18.0–18.8) (11.5–12.2)
Blue-collar worker, % 69.8 71.3 74.2 75.2 <0.0001 <0.0001
(95 % CI)b (69.6–70.0) (70.7–71.9) (73.7–74.6) (74.7–75.6)
Smoking status, % (95 % CI)b
Never smoker 38.9 29.5 38.6 30.1 <0.0001 <0.0001
(38.6–39.1) (28.9–30.1) (38.1–39.1) (29.6–30.6)
Former smoker
(stopped smoking ≥1 year ago)
15.2 20.3 16.8 21.4
(15.0–15.4) (19.7–20.8) (16.4–17.2) (20.9–21.8)
Former smoker
(stopped smoking <1 year ago)
3.2 3.5 3.3 3.7
(3.1–3.3) (3.3–3.8) (3.2–3.5) (3.5–4.0)
Current smoker 42.7 46.8 41.3 44.8
(42.5–43.0) (46.1–47.4) (40.8–41.8) (44.2–45.3)
Heavy drinker, % 2.1 3.0 2.1 3.3 0.8921 0.078
(95 % CI)b (2.1–2.2) (2.8–3.3) (2.0–2.3) (3.1–3.5)
Physical exercised, % (95 % CI)b
Regular physical exercise 21.5 14.6 15.9 11.4 <0.0001 <0.0001
(21.0–21.9) (13.5–15.8) (15.2–16.6) (10.7–12.3)
≥2 h/week of physical exercise 10.2 10.2 10.7 9.0
(9.9–10.6) (9.2–11.2) (10.1–11.3) (8.3–9.8)
<2 h/week physical exercise 16.5 15.3 14.8 13.0
(16.1–16.9) (14.2–16.5) (14.2–15.5) (12.2–13.9)
No physical exercise 51.8 59.9 58.6 66.5
(51.3–52.3) (58.3–61.5) (57.6–59.5) (65.3–67.7)
Systolic blood pressure (mmHg),
mean [SD]c (95 % CI)b
127.3 [15.2] 139.9 [16.0] 130.4 [15.9] 141.6 [16.8] <0.0001 <0.0001














Table 1 Characteristics of the study population by metabolic phenotype among overweight and obese individuals (Continued)
Diastolic blood pressure (mmHg),
mean [SD]c (95 % CI)b
76.8 [10.1] 84.3 [10.2] 79.6 [10.6] 86.2 [10.8] <0.0001 <0.0001
(76.8–76.9) (84.1–84.4) (79.5–79.7) (86.1–86.3)
Hypertension, % 44.6 89.6 52.2 89.1 <0.0001 0.0810
(95 % CI)b (44.4–44.9) (89.2–90.0) (51.7–52.7) (88.8–89.5)
HDL cholesterol (mg/dL),
mean [SD]c (95 % CI)b
51.4 [12.0] 43.1 [11.3] 50.4 [11.3] 43.8 [10.7] <0.0001 <0.0001
(51.3–51.4) (42.9–43.2) (50.3–50.5) (43.6–43.9)
Triglycerides (mg/dL),
mean [SD]c (95 % CI)b
109.2 [70.0] 210.1 [133.4] 114.2 [69.1] 198.1 [127.7] <0.0001 <0.0001
(108.9–109.6) (208.3–211.8) (113.5–114.9) (196.7–199.5)
Hypertriglyceridemia, % 17.3 77.9 15.5 66.9 <0.0001 <0.0001
(95 % CI)b (17.1–17.5) (77.3–78.4) (15.2–15.9) (66.4–67.4)
Total cholesterol (mg/dL),
mean [SD]c (95 % CI)b
201.4 [40.5] 217.5 [44.0] 203.9 [38.6] 216.1 [42.6] <0.0001 0.0003
(201.2–201.6) (216.9–218.1) (203.5–204.3) (215.6–216.6)
Hypercholesterolemia, % 50.2 69.0 53.0 66.9 <0.0001 <0.0001
(95 % CI)b (49.9–50.4) (68.4–69.6) (52.5–53.5) (66.4–67.5)
Glucose level (mg/dL),
mean [SD]c (95 % CI)
89.2 [14.7] 107.4 [33.0] 89.5 [12.9] 106.7 [33.3] 0.0008 0.0092
(89.1–89.3) (107.0–107.9) (89.3–89.6) (106.3–107)
BMI (kg/m2),
mean [SD]c (95 % CI)b
27.1 [1.4] 27.8 [1.4] 32.6 [3.0] 33.7 [3.4] <0.0001 <0.0001
(27.1–27.1) (27.8–27.9) (32.5–32.6) (33.7–33.7)
Waist circumference (cm),
mean [SD]c (95 % CI)b
91.1 [7.5] 97.6 [7.5] 102.1 [9.7] 109.2 [9.0] <0.0001 <0.0001
(91.1–91.2) (97.5–97.7) (102–102.2) (109.1–109.3)
*P-values correspond to chi-squared test for categorical data, and t-test for continuous variables
aBMI: body mass index
b95% CI: 95 % confidence interval
cSD: standard deviation














Table 2 Characteristics of the study population by metabolic phenotype among obese I, II and III individuals
Characteristics Obese I (BMIa 30.00–34.99 kg/m2) Obese II (BMIa 35.00–39.99 kg/m2) Obese III (BMIa 40.00 kg/m2) p-value*
n = 56,478 n = 10,878 n = 2,696
Healthy Unhealthy Healthy Unhealthy Healthy Unhealthy Healthy Unhealthy
n = 33,205 n = 23,273 n = 4,352 n = 6,526 n = 1,043 n = 1,653
Prevalence, % 7.4 5.2 1.0 1.4 0.2 0.4
(95 % CI)b (7.3–7.4) (5.1–5.2) (0.9–1.0) (1.4–1.5) (0.2–0.2) (0.3–0.4)
Age (years), mean [SD] c (95 % CI)b 37.9 [10.7] 43.5 [10.6] 36.6 [10.6] 41.5 [10.8] 35.8 [9.9] 39.8 [10.3] <0.0001 <0.0001
(37.8–38.0) (43.3–43.6) (36.2–36.9) (41.2–41.7) (35.2–36.4) (39.3–40.3)
Female, % 16.6 10.5 28.2 14.1 34.2 22.3 <0.0001 <0.0001
(95 % CI)b (16.2–17.0) (10.1–10.9) (26.9–29.6) (13.3–14.9) (31.3–37.1) (20.4–24.4)
Blue-collar worker, % 74.1 74.6 75.0 77.4 72.3 74.1 0.1984 <0.0001
(95 % CI)b (73.7–74.6) (74–75.2) (73.7–76.3) (76.4–78.4) (69.5–75) (71.9–76.1)
Smoking status, % (95 % CI)b
Never smoker 38.4 29.7 39.1 31.1 42.0 32.3 0.0097 <0.0001
(37.9–38.9) (29.1–30.3) (37.7–40.6) (29.9–32.2) (39.0–45.0) (30.1–34.6)
Former smoker
(stopped smoking ≥1 year ago)
17.0 22.3 15.8 18.6 13.6 18.6
(16.6–17.4) (21.8–22.9) (14.7–16.9) (17.7–19.6) (11.7–15.8) (16.8–20.6)
Former smoker
(stopped smoking <1 year ago)
3.4 3.7 3.1 3.7 2.7 3.8
(3.2–3.6) (3.5–4.0) (2.7–3.7) (3.3–4.2) (1.9–3.9) (2.9–4.8)
Current smoker 41.2 44.2 42.0 46.6 41.7 45.3
(40.7–41.7) (43.6–44.9) (40.5–43.4) (45.4–47.8) (38.8–44.7) (42.9–47.7)
Heavy drinker, % 2.2 3.3 2.0 3.4 2.5 2.8 0.6390 0.5314
(95 % CI)b (2.0–2.3) (3.1–3.6) (1.6–2.5) (3.0–3.8) (1.7–3.6) (2.1–3.8)
Physical exercised,
% (95 % CI)b
Regular physical exercise 16.3 12.0 14.0 10.2 14.4 9.0 0.0012 0.1334
(15.5–17.1) (11.1–13.0) (12.3–16.0) (8.7–11.9) (11.1–18.5) (6.6–12.3)
≥2 h/week of physical exercise 10.9 9.1 9.8 9.3 8.6 7.2
(10.3–11.6) (8.3–10.0) (8.3–11.5) (7.9–10.9) (6.1–12.1) (5.1–10.3)
<2 h/week physical exercise 15.1 13.3 14.4 12.3 9.8 12.9
(14.4–15.9) (12.3–14.3) (12.6–16.3) (10.7–14.2) (7.1–13.4) (9.9–16.6)
No physical exercise 57.7 65.6 61.8 68.2 67.1 70.8














Table 2 Characteristics of the study population by metabolic phenotype among obese I, II and III individuals (Continued)
Systolic blood pressure
(mmHg), mean [SD]c (95 % CI)b
130.2 [15.8] 141.2 [16.6] 131.2 [16.5] 142.7 [17.3] 132.2 [17.8] 143.8 [17.1] <0.0001 <0.0001
(130.1–130.4) (141–141.4) (130.7–131.7) (142.3–143.2) (131.1–133.2) (143–144.6)
Diastolic blood pressure
(mmHg), mean [SD]c (95 % CI)b
79.4 [10.5] 85.8 [10.6] 80.6 [10.9] 87.1 [11.1] 81.8 [12.3] 88.1 [11.4] <0.0001 <0.0001
(79.3–79.5) (85.6–85.9) (80.3–81.0) (86.9–87.4) (81.1–82.5) (87.5–88.6)
Hypertension, % 52.1 88.6 52.5 90.4 56.0 90.9 0.036 <0.0001
(95 % CI)b (51.5–52.6) (88.2–89.0) (51.0–54.0) (89.7–91.1) (53.0–59.0) (89.5–92.2)
HDL cholesterol (mg/dL),
mean [SD]c (95 % CI)b
50.3 [11.3] 43.8 [10.7] 51.1 [11.3] 43.4 [10.4] 51.3 [11.4] 43.8 [10.6] <0.0001 0.0257
(50.2–50.4) (43.7–44.0) (50.8–51.4) (43.2–43.7) (50.6–52.0) (43.2–44.3)
Triglycerides (mg/dL),
mean [SD]c (95 % CI)b
115.7 [71.7] 200.0 [130.0] 105.7 [49.2] 194.3 [121.8] 103.8 [50.2] 186.2 [116.6] <0.0001 <0.0001
(114.9–116.4) (198.3–201.6) (104.2–107.2) (191.4–197.3) (100.6–106.7) (180.6–191.9)
Hypertriglyceridemia, % 16.7 68.1 8.8 64.6 6.8 59.0 <0.0001 <0.0001
(95 % CI)b (16.3–17.1) (67.5–68.7) (8.0–9.7) (63.4–65.8) (5.4–8.5) (56.6–61.4)
Total cholesterol (mg/dL),
mean [SD]c (95 % CI)b
204.6 [38.7] 217.4 [42.7] 199.9 [37.6] 213.5 [42.2] 196.4 [35.2] 208.4 [40.5] <0.0001 <0.0001
(204.2–205.0) (216.8–217.9) (198.8–201) (212.5–214.5) (194.3–198.6) (206.5–210.4)
Hypercholesterolemia, % 53.8 68.3 48.8 64.2 45.4 58.7 <0.0001 <0.0001
(95 % CI)b (53.2–54.3) (67.7–68.9) (47.3–50.3) (63.0–65.4) (42.4–48.4) (56.3–61.0)
Glucose level (mg/dL), mean [SD]c
(95 % CI)
89.6 [13.1] 106.3 [32.6] 88.5 [11.5] 107.2 [34.8] 87.7 [10.0] 109.4 [37.3] <0.0001 0.0021
(89.5–89.8) (105.9–106.8) (88.2–88.9) (106.3–108.0) (87.1–88.3) (107.6–111.2)
BMI (kg/m2), mean [SD]c (95 % CI)b 31.7 [1.3] 32.1 [1.4] 36.8 [1.3] 36.9 [1.4] 44.2 [5.7] 43.3 [4.3] <0.0001 <0.0001
(31.6–31.7) (32.1–32.1) (36.7–36.8) (36.8–36.9) (43.9–44.7) (43.2–43.7)
Waist circumference (cm),
mean [SD]c (95 % CI)b
100.6 [8.2] 106.4 [6.8] 110.1 [10.9] 115.1 [8.2] 116.3 [16.8] 125 [10.7] <0.0001 <0.0001
(100.5–100.7) (106.3–106.5) (109.8–110.4) (114.9–115.2) (115.2–117.3) (124.5–125.5)
* P-values correspond to chi-squared test for categorical data, and one-way ANOVA for continuous variables
aBMI: body mass index
b95% CI: 95 % confidence interval
cSD: standard deviation














Table 3 Characteristics of the study population by metabolic phenotype among underweight and normal weight individuals
Characteristics Underweight (BMIa <18.50 kg/m2) Normal weight (BMIa 18.50–24.99 kg/m2) p-value*
n = 7,747 n = 202,265
Healthy Unhealthy Healthy Unhealthy Healthy Unhealthy
n = 7,711 n = 36 n = 197,846 n = 4,419
Prevalence, % 1.7 0.0 43.8 1.0
(95 % CI)b (1.7–1.7) (0.0–0.0) (43.7–44) (1.0–1.0)
Age (years), mean [SD]c (95 % CI)b 28.4 [8.3] 38.6 [12.4] 32.8 [9.7] 41.8 [11.4] <0.0001 0.0988
(28.2–28.6) (34.4–42.8) (32.7–32.8) (41.4–42.1)
Female, % 66.2 16.7 40.7 16.2 <0.0001 0.9403
(95 % CI)b (65.2–67.3) (7.9–31.9) (40.4–40.9) (15.1–17.3)
Blue-collar worker, % 54.7 66.7 60.4 72.8 <0.0001 0.4176
(95 % CI)b (53.5–55.8) (50.3–79.8) (60.2–60.7) (71.5–74.1)
Smoking status, % (95 % CI)b
Never smoker 37.6 11.1 39.3 26.3 <0.0001 0.0570
(36.5–38.7) (4.4–25.3) (39.1–39.6) (25–27.6)
Former smoker (stopped smoking ≥1 year ago) 5.6 16.7 9.4 13.6
(5.1–6.1) (7.9–31.9) (9.3–9.6) (12.6–14.6)
Former smoker (stopped smoking <1 year ago) 2.4 0.0 2.7 2.8
(2.1–2.8) (0.0–9.6) (2.6–2.7) (2.4–3.3)
Current smoker 54.5 72.2 48.6 57.4
(53.4–55.6) (56.0–84.2) (48.3–48.8) (55.9–58.8)
Heavy drinker, % 1.3 2.8 1.8 3.5 0.0001 0.8113
(95 % CI)b (1.0–1.5) (0.5–14.2) (1.8–1.9) (3.0–4.1)
Physical exercised, % (95 % CI)b
Regular physical exercise 16.6 0.0 23.1 16.2 <0.0001 0.5628
(15.1–18.2) (0.0–43.4) (22.7–23.5) (13.6–19.2)
≥2 h/week of physical exercise 9.1 20.0 9.7 10.9
(8.0–10.4) (3.6–62.4) (9.5–10.0) (8.7–13.4)
<2 h/week physical exercise 11.9 20.0 16.0 13.7
(10.6–13.4) (3.6–62.4) (15.7–16.4) (11.3–16.5)
No physical exercise 62.3 60.0 51.1 59.2
(60.3–64.4) (23.1–88.2) (50.7–51.6) (55.5–62.9)
Systolic blood pressure (mmHg), mean [SD]c (95 % CI)b 112.5 [13.5] 136.7 [14.9] 119.8 [14.5] 138.1 [15.3] <0.0001 0.5729














Table 3 Characteristics of the study population by metabolic phenotype among underweight and normal weight individuals (Continued)
Diastolic blood pressure (mmHg), mean [SD]c (95 % CI)b 69.4 [9.3] 83.3 [11.2] 72.2 [9.5] 82.3 [10.3] <0.0001 0.5457
(69.2–69.6) (79.5–87.1) (72.2–72.3) (82.0–82.6)
Hypertension, % 12.9 86.1 26.2 90.7 <0.0001 0.3732
(95 % CI)b (12.2–13.7) (71.3–93.9) (26.0–26.4) (89.8–91.5)
HDL cholesterol (mg/dL), mean [SD]c (95 % CI)b 60.4 [14.7] 43.4 [14.4] 56.5 [13.9] 43.5 [12.4] <0.0001 0.9765
(60.1–60.8) (38.6–48.3) (56.5–56.6) (43.1–43.9)
Triglycerides (mg/dL), mean [SD]c (95 % CI)b 68.5 [31.1] 226.4 [246.2] 82.5 [50.2] 209.2 [133.7] <0.0001 0.6787
(67.8–69.2) (143.1–309.7) (82.3–82.7) (205.3–213.2)
Hypertriglyceridemia, % 2.4 75.0 7.0 83.1 <0.0001 0.2215
(95 % CI)b (2.1–2.8) (58.9–86.2) (6.9–7.2) (82.0–84.2)
Total cholesterol (mg/dL), mean [SD]c (95 % CI)b 172.3 [33.7] 194.7 [51.4] 185.6 [37.4] 209.8 [45.5] <0.0001 0.0480
(171.6–173.1) (177.3–212.1) (185.4–185.8) (208.4–211.1)
Hypercholesterolemia, % 19.8 47.2 33.1 61.0 <0.0001 0.0965
(95 % CI)b (18.9–20.7) (32.0–63.0) (32.9–33.3) (59.5–62.4)
Glucose level (mg/dL), mean [SD]c (95 % CI)b 82.6 [12.5] 105.4 [38.5] 85.6 [13.9] 108.3 [38.7] <0.0001 0.6625
(82.3–82.9) (92.4–118.4) (85.5–85.6) (107.1–109.4)
BMI (kg/m2), mean [SD]c (95 % CI)b 17.7 [0.7] 16.8 [1.6] 22.4 [1.7] 23.5 [1.3] <0.0001 <0.0001
(17.7–17.7) (16.3–17.3) (22.4–22.4) (23.4–23.5)
Waist circumference (cm), mean [SD]c (95 % CI)b 67.9 [6.4] 84.4 [17.5] 78.6 [8.1] 86.8 [8.3] <0.0001 0.4090
(67.7–68.0) (78.4–90.3) (78.6–78.6) (86.6–87.1)
* P-values correspond to chi-squared test for categorical data, and t-test for continuous variables
aBMI: body mass index
b95% CI: 95 % confidence interval
cSD: standard deviation














































Fig. 1 Prevalence of metabolically healthy/unhealthy individuals in the different BMI categories
Goday et al. BMC Public Health  (2016) 16:248 Page 10 of 14were metabolically unhealthy were more likely to be older,
male, blue-collar workers, smokers, and heavy drinkers
(Table 3). Within the metabolically unhealthy normal
weight phenotype group, the proportion of individuals
with a sedentary lifestyle was higher relative to that in the
metabolically healthy normal weight phenotype group.
There were no notable differences in metabolic risk
factors between metabolically unhealthy individuals who
were underweight or normal weight, with the exceptions
of mean triglyceride levels, which were higher among
underweight individuals compared with normal weight
individuals (226.4 vs. 209.2 mg/dL), and total cholesterol
levels, which were lower among underweight individuals
(194.7 vs. 209.8 mg/dL); however, only the differences in
total cholesterol levels were statistically significant (p =
0.0480) (Table 3).
In the underweight category, mean triglyceride levels
of individuals in the metabolically unhealthy phenotype
were 226.4 mg/dL; for individuals in the metabolically
healthy phenotype, they were 68.5 mg/dL. The greatest
difference in mean waist circumference between meta-
bolically unhealthy and healthy phenotypes was observed
among underweight individuals (84.4 versus 67.9 cm). In
the normal weight category, mean triglyceride levels
were 209.2 mg/dL in metabolically unhealthy individuals
and 82.5 mg/dL in metabolically healthy individuals.Among underweight or normal weight individuals who
were metabolically unhealthy, mean total cholesterol
levels were 194.7 and 209.8 mg/dL, respectively, and
underweight or normal weight individuals who were
metabolically healthy had mean total cholesterol levels
of 172.3 and 185.6 mg/dL, respectively.
Factors associated with the metabolic unhealthy
phenotype
In a regression model, the factors most strongly associ-
ated with the metabolic unhealthy phenotype were BMI
and age (Table 4). Individuals who were underweight
had a lower likelihood of having a metabolic unhealthy
phenotype compared with those with normal weight (ad-
justed odds ratio [aOR] 0.25; 95 % CI 0.11–0.62). Obese
individuals had a marked increase in the likelihood of
exhibiting a metabolic unhealthy phenotype compared
with normal weight individuals, ranging from an aOR
of 24 (95 % CI, 22–26) among those in the obese I cat-
egory to an aOR of 67 (95 % CI, 56–80) among indi-
viduals in the obese III category. Increased age was
associated with increased likelihood of expressing a
metabolically unhealthy phenotype (35–44 years versus
≤34 years: aOR 1.94, 95 % CI 1.83–2.07; 45–54 years
versus ≤34 years: aOR 3.18, 95 % CI 2.97–3.40; ≥55 years
versus ≤34 years: aOR 4.95, 95 % CI 4.55–5.39). There was
Table 4 Factors associated with expression of a metabolically unhealthy phenotype (unadjusted and multivariate analyses)
Factor Crude ORa p-value Adjusted ORa p-value
95 % CIb 95 % CIb
Age (years) <0.0001 <0.0001
≤34 1.00 - 1.00 -
35–44 2.67 <0.0001 1.94 <0.0001
(2.61–2.73) (1.83–2.07)
45–54 5.01 <0.0001 3.18 <0.0001
(4.89–5.14) (2.97–3.40)
55 7.72 <0.0001 4.95 <0.0001
(7.50–7.95) (4.55–5.39)
Male [Female] 3.07 <0.0001 1.63 <0.0001
(3.00–3.15) (1.53–1.75)
Body Mass Index (kg/m2) <0.0001 <0.0001
18.50–24.99 1.00 - 1.00 -
<18.50 0.21 <0.0001 0.25 0.0023
(0.15–0.29) (0.11–0.61)
25.00–29.99 6.64 <0.0001 4.98 <0.0001
(6.43–6.86) (4.56–5.44)
30.00–34.99 31.38 <0.0001 23.93 <0.0001
(30.32–32.47) (21.89–26.16)
35.00–39.99 67.14 <0.0001 55.53 <0.0001
(63.95–70.48) (49.54–62.24)
≥40.00 70.96 <0.0001 67.29 <0.0001
(65.3–77.10) (56.39–80.30)
Blue collar [White collar] 1.48 <0.0001 1.04 0.1680
(1.45–1.51) (0.98–1.10)
Smoking status <0.0001 <0.0001
Never smoker 1.00 - 1.00 -
Former smoker
(stopped smoking ≥1 year ago)
2.19 <0.0001 1.13 0.0008
(2.14–2.25) (1.05–1.22)
Former smoker
(stopped smoking <1 year ago)
1.61 <0.0001 1.34 0.0002
(1.54–1.70) (1.15–1.56)
Current smoker 1.34 <0.0001 1.33 <0.0001
(1.32–1.37) (1.26–1.41)




2.92 <0.0001 1.77 <0.0001
(2.87–2.98) (1.68–1.86)
Physical exercise <0.0001 <0.0001
Regular physical exercise 1.00 - 1.00 -
≥2 h/week of physical exercise 1.61 <0.0001 1.25 <0.0001
(1.47–1.75) (1.13–1.38)
<2 h/week physical exercise 1.46 <0.0001 1.19 0.0001
(1.35–1.58) (1.09–1.30)
No physical exercise 2.05 <0.0001 1.42 <0.0001
(1.93–2.18) (1.32–1.52)
aOR: odds ratio
b95 % CI: 95 % confidence interval
Reference categories for binary outcomes are included within square brackets
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55 years or older compared with those aged ≤34 years.
Other factors associated with the metabolically unhealthy
phenotype were the presence of hypercholesterolemia,
male sex, smoking, heavy drinking, and no physical
exercise.
Because physical exercise was recorded only in one
fourth of the study participants (n = 100,561), we per-
formed another regression analysis excluding this factor.
The results of this analysis were almost identical to
those reported for the full model (data not shown).
Discussion
The prevalence of obesity (15.5 %) and overweight (38 %)
in our sample was similar to that reported for Spanish
young adults (18–44 years) in the general population (15
and 33.4 %, respectively) [15]. The prevalence of the MHO
phenotype (8.6 %) in our study, in a working population
and using the modified NCEP-ATPIII criteria, is within the
range reported in the literature (2–12 %) for the general
population [5]; however, it was higher than that reported
for the general population in the ENRICA study in Spain
(6.5 %) [16]. Subjects from the ENRICA study were older,
and more importantly, they were considered metabolically
healthy if they had fewer than 2 cardio-metabolic abnor-
malities [16]. These differences may explain the lower
prevalence of MHO in the ENRICA study compared with
our results. In our study, even among the most obese sub-
jects, the prevalence of metabolic health was relatively high.
Thus, approximately 40 % of individuals in the obese II and
III categories were considered to be metabolically healthy.
Certainly, these results are influenced by which definition
of metabolic health is used. When we used the stricter cri-
teria of not having any criterion of metabolic syndrome,
none of these individuals were metabolically healthy. A de-
tailed discussion of the definition of metabolically healthy
obesity and its implications can be found elsewhere [5]. We
are not aware of other studies on prevalence of the MHO
phenotype conducted in the working population.
According to our regression analysis, the factors associ-
ated with a metabolically unhealthy phenotype were BMI,
age, presence of hypercholesterolemia, male sex, being a
smoker or heavy drinker, and undertaking no physical exer-
cise. There are limited data available on the determinants
of metabolic health status [5]. Our results in this regard are
not fully consistent with those reported by Lopez-García
et al. in a representative sample of the Spanish general
population [16]. Although the role of age, sex and physical
exercise was the same as in our study, they found that the
likelihood of being metabolically healthy (that is, having
0–1 cardio-metabolic abnormalities) in obese individuals
was higher in current smokers. Among normal weight in-
dividuals, the likelihood of being metabolically unhealthy
was lower in former and current smokers. Regardingalcohol consumption, the categories used in both studies
are not equivalent and, therefore, it is difficult to make
any comparison. In our study we found that, for any of
the BMI categories, individuals that consumed 14 or more
standard drinks per week (heavy drinkers) were more
likely to be metabolically unhealthy. Wildman et al., in a
representative sample of the US non-institutionalized
population, after adjusting for waist circumference, found
that among overweight and obese individuals, younger
age, non-Hispanic Black race/ethnicity, moderate physical
exercise levels and smaller waist circumference were inde-
pendently associated with a metabolically healthy pheno-
type [17]. Our findings and those of Wildman et al. [17]
suggest the usefulness of targeting modifiable factors with
lifestyle interventions. MHO seems to be a transient status
[5, 18]; therefore, a sound approach would be to identify
metabolically healthy overweight or obese individuals and
to initiate lifestyle interventions to avoid their progression
to an unhealthy phenotype. The results of a recent pro-
spective study conducted in Spain support this approach
[19]. These authors found that a healthy lifestyle (mea-
sured with an index that combined diet quality, physical
exercise, and smoking status) was associated with a signifi-
cant lower likelihood of transition to a metabolically ab-
normal overweight/obese phenotype [19].
Apart from the frequency of hypertension, the most
common metabolic risk factor among metabolically un-
healthy underweight or normal weight individuals, when
compared with those who were metabolically healthy,
was an increased level of triglycerides and a greater
mean waist circumference. This phenotype overlaps the
so-called hypertriglyceridemic waist phenotype. The
presence of this phenotype has been associated with sub-
clinical atherosclerosis [20], incident diabetes [21, 22],
and an increased risk of coronary artery disease [23, 24].
In fact, some authors have reported that evaluating the
presence of the hypertriglyceridemic waist phenotype is
as discriminant as the NCEP-ATP III or the Inter-
national Diabetes Federation criteria for identifying indi-
viduals at increased cardio-metabolic risk [25]. Although
we have not analyzed the concordance between the
hypertriglyceridemic waist phenotype and the metabolic-
ally unhealthy phenotype, our results appear to support
the usefulness of the hypertriglyceridemic-waist pheno-
type for identifying individuals who are metabolically
unhealthy.
In underweight and normal weight individuals who were
metabolically unhealthy, the proportion of blue-collar
workers was 66.7 and 72.8 %, respectively, and among
those with the healthy phenotype, the corresponding fig-
ures were 54.7 and 60.4 %, respectively. Albeit speculative,
these differences may be related to differences in lifestyle
characteristics. In a study conducted in Finland, unskilled
blue-collar workers had more cardiovascular risk factors
Goday et al. BMC Public Health  (2016) 16:248 Page 13 of 14(namely, smoking, hypertension, and reduced physical ex-
ercise during leisure time) than white-collar workers [26].
The high proportion of obese subjects who are meta-
bolically healthy also suggests that BMI is not sufficient
as a marker of cardio-metabolic risk and, therefore, that
there is a need for the development and validation of
other markers that may help to guide treatment-decision
making [27].
Our study has several limitations. Its cross-sectional
design does not allow us to establish causal relation-
ships. In fact, when evaluating the factors associated
with the metabolically unhealthy phenotype, the direc-
tion of the association was assumed to be that evaluated
in the model. In our study, there is a lack of information
regarding some other variables that have been used to
define metabolic health status such as the homeostatic
model assessment of insulin resistance (HOMA-IR).
However, it should be noted that there is not a standard-
ized cut-off value of HOMA-IR to define metabolic
health [18]. The strengths of this study include the sam-
ple size, the study setting, using a sample that is repre-
sentative of the Spanish working population, and the
analysis of a subpopulation that has scarcely been inves-
tigated, namely underweight individuals.
Conclusions
Our study shows that prevalence of MHO individuals in
a large sample of the working population is high, corre-
sponding to more than half of the obese individuals. The
factors associated with the presence of the metabolically
unhealthy phenotype include several modifiable risk fac-
tors such as relative weight, smoking, heavy drinking,
and no physical exercise. Detecting, at an early stage,
obese and overweight individuals who are metabolically
healthy may be useful to reduce the likelihood of transi-
tion to a metabolically unhealthy phenotype by allowing
targeting of the aforementioned risk factors with lifestyle
modification initiatives. The working environment seems
an appropriate setting to implement those initiatives in
conjunction with the Public Health Services.
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